| Circadian hepatocyte clocks keep synchrony in the absence of a master pacemaker in the suprachiasmatic nucleus or other extrahepatic clocks F Sinturel, P Gos, V Petrenko, C Hagedorn, F Kreppel, KF Storch, D Knutti, ... Genes & development 35 (5-6), 329-334, 2021 | 62 | 2021 |
| Apolipoprotein E interrupts interleukin-1β signaling in vascular smooth muscle cells A Kawamura, D Baitsch, R Telgmann, R Feuerborn, G Weissen-Plenz, ... Arteriosclerosis, thrombosis, and vascular biology 27 (7), 1610-1617, 2007 | 51 | 2007 |
| Impact of common KIBRA allele on human cognitive functions H Wersching, K Guske, S Hasenkamp, C Hagedorn, S Schiwek, S Jansen, ... Neuropsychopharmacology 36 (6), 1296-1304, 2011 | 47 | 2011 |
| S/MAR element facilitates episomal long-term persistence of adeno-associated virus vector genomes in proliferating cells C Hagedorn, M Schnoedt-Fuchs, P Boehme, H Abdelrazik, HJ Lipps, ... Human gene therapy 28 (12), 1169-1179, 2017 | 43 | 2017 |
| Genomic cis-acting sequences improve expression and establishment of a nonviral vector C Hagedorn, MN Antoniou, HJ Lipps Molecular Therapy-Nucleic Acids 2, 2013 | 37 | 2013 |
| Scaffold/Matrix Attached Region-Based Nonviral Episomal Vectors C Hagedorn, SP Wong, R Harbottle, HJ Lipps Human gene therapy 22 (8), 915-923, 2011 | 32 | 2011 |
| Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study U Hillebrand, D Lang, RG Telgmann, C Hagedorn, S Reuter, K Kliche, ... Journal of hypertension 27 (3), 517-526, 2009 | 32 | 2009 |
| Molecular genetic analysis of a human insulin‐like growth factor 1 promoter P1 variation R Telgmann, C Dördelmann, E Brand, V Nicaud, C Hagedorn, ... The FASEB Journal 23 (5), 1303-1313, 2009 | 30 | 2009 |
| Capsid and genome modification strategies to reduce the immunogenicity of adenoviral vectors F Kreppel, C Hagedorn International Journal of Molecular Sciences 22 (5), 2417, 2021 | 23 | 2021 |
| Controlled removal of a nonviral episomal vector from transfected cells S Rupprecht, C Hagedorn, D Seruggia, T Magnusson, E Wagner, M Ogris, ... Gene 466 (1-2), 36-42, 2010 | 23 | 2010 |
| Capsid engineering of adenovirus vectors: overcoming early vector–host interactions for therapy C Hagedorn, F Kreppel Human Gene Therapy 28 (10), 820-832, 2017 | 20 | 2017 |
| Genetic and chemical capsid modifications of adenovirus vectors to modulate vector–host interactions D Weklak, D Pembaur, G Koukou, F Jönsson, C Hagedorn, F Kreppel Viruses 13 (7), 1300, 2021 | 18 | 2021 |
| Functional and structural profiling of the human thrombopoietin gene promoter C Dordelmann, R Telgmann, E Brand, C Hagedorn, B Schroer, ... Journal of biological chemistry 283 (36), 24382-24391, 2008 | 17 | 2008 |
| SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE Study R Telgmann, E Brand, V Nicaud, C Hagedorn, K Beining, J Schönfelder, ... Journal of hypertension 25 (3), 557-564, 2007 | 17 | 2007 |
| The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1+ CD8+ T cells in chronic viral infection AF Marx, SM Kallert, TM Brunner, JA Villegas, F Geier, J Fixemer, ... Immunity 56 (4), 813-828. e10, 2023 | 15 | 2023 |
| Viral hybrid-vectors for delivery of autonomous replicons W Zhang, C Hagedorn, E Schulz, HJ Lipps, A Ehrhardt Current Gene Therapy 14 (1), 10-23, 2014 | 15 | 2014 |
| Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoter C Hagedorn, R Telgmann, C Dördelmann, B Schmitz, S Hasenkamp, ... Arteriosclerosis, thrombosis, and vascular biology 29 (10), 1638-1643, 2009 | 15 | 2009 |
| Osteopontin gene variation and cardio/cerebrovascular disease phenotypes K Schmidt-Petersen, E Brand, R Telgmann, V Nicaud, C Hagedorn, ... Atherosclerosis 206 (1), 209-215, 2009 | 15 | 2009 |
| A colony-forming assay for determining the establishment efficiency of S/MAR-containing nonviral episomal expression vectors C Hagedorn, A Baiker, J Postberg, A Ehrhardt, HJ Lipps Cold Spring Harbor protocols 2012 (6), pdb. prot069500, 2012 | 12 | 2012 |
| Characterization and functional analyses of the human G protein–coupled receptor kinase 4 gene promoter S Hasenkamp, R Telgmann, JA Staessen, C Hagedorn, C Dördelmann, ... Hypertension 52 (4), 737-746, 2008 | 12 | 2008 |
